OBJECTIVES:
Primary
- Determine the 2-month objective response rate in patients with locally advanced or metastatic, unresectable soft tissue angiosarcoma or lymphangiosarcoma treated with paclitaxel.
Secondary
- Determine the 4- and 6-month response rate in patients treated with this drug.
-